Resumen La necesidad de transformar la docencia presencial a docencia online debido al COVID-19 supuso un reto para docentes y para alumnos. Lo inesperado de la situación hizo que rápidamente se intentaran establecer estrategias de virtualización que no en todos los casos fueron igual de eficaces. Después de un año de docencia online, es interesante analizar la valoración que tanto docentes como estudiantes realizan a todas estas estrategias y conocer su percepción ante esta situación. En este artículo se recoge la valoración de más de 50 alumnos del grado de Farmacia sobre la docencia online teórica, la docencia online práctica y la evaluación online, destacando las ventajas y limitaciones que suponen estos métodos de enseñanza. También se recoge la valoración de docentes que evalúan de forma positiva todo lo aprendido sobre TICs y nuevas plataformas pero que al igual que los alumnos piensan que el entorno no presencial supone una desventaja para la formación de los alumnos en grados con una importante carga de docencia práctica.

Abstract The COVID -19 pandemic forced to move from face-to-face teaching to completely virtual teaching, which was a great challenge for both teachers and students. The unexpectedness of the situation led to rapid attempts to establish virtualization strategies, which were not always equally effective. After one year of online teaching, it is interesting to analyze the assessment that both teachers and students make of all these strategies and their perception of this situation. This manuscript collects the analysis of more than 50 students of the Pharmacy degree on both, theoretical and practical online lessons and on online exams, highlighting their advantages and limitations. Teacher’s assessment is also included. On the one hand, teachers positively value all that they have learned about information and communication technologies (ICTs) and the developed online teaching platforms. However, they consider that a completely virtual education impairs the learning, especially in practical lessons.

Natural deep eutectic solvents (NADES) based on xylitol, citric acid, and malic acid were synthesized and used in ultrasound-assisted extraction (UAE) and heating-bath extraction of phosphate rock and mineral supplement samples. Arsenic, Ca, Cd, Cr, Cu, Fe, K, Mg, Mn, Na, P and Zn were determined by inductively coupled plasma mass spectrometry (ICP-MS) and inductively coupled plasma optical emission spectrometry (ICP OES). The results showed the NADES as promising solvents for extraction of inorganic matrices compared to reference values and concentrations obtained using microwave-assisted acid digestion (MW-AD). Significant differences were observed for some elements, suggesting different chemical interactions between the synthesized NADES and each monitored element. For analytes extraction of phosphate rock, UAE presented the best results for As, Cr and P. Zinc was extracted with UAE and heating bath. Concerning mineral supplement, no significant differences were observed for Ca (UAE), Cd (UAE and heating bath), K (UAE and heating bath), Mn (UAE and heating bath), Na (UAE and heating bath), and P (UAE and heating bath). The NADES is a greener and a potentially alternative for the sample preparation compared to the official methods of analysis, can being used as selective extractor solvent in conventional sample preparation methods.

Cannabis sativa has many promising medicinal applications for the mitigation, or even cure, of chronic diseases. The high bioaccumulation potential of C. sativa enables its use for the phytoremediation and detoxification of soil, may increase the levels of inorganic elements in products such as cannabidiol (CBD) extracts being necessary the evaluation/monitoring of the level of inorganic components, mainly the toxic species in these formulations. An analytical method employing graphite furnace atomic absorption spectrometry (GFAAS) was developed for the quantification of Pb, As, and Cd in commercial CBD extracts and homemade samples. The alkaline solubilization was employed in agreement with the external analytical curve, in a robust method. The limits of quantification were 0.26 (Pb), 0.067 (As), and 0.011 µg g-1 (Cd), with satisfactory accuracy (80-120%) and relative standard deviation (RSD) values < 7%. The CBD extracts presented levels of Pb, As and Cd below the maximum limits established by regulatory agencies.

Peyronie's disease is a medical condition characterized by an abnormal curvature of the penis, which presents a poorly understood pathophysiology, featuring abnormal fibroblasts of the tunica albuginea secondary to trauma or stemming from congenital causes. Currently, there are multiple therapeutic options, such as oral pharmacological treatments that either report poor results or partial improvements, as well as intralesional therapies viewed as controversial and surgery as a therapeutic choice. However, this can be implemented once the disease is in its stable phase. A number of alternatives can be elected regarding the needs and symptoms of patients.

The concentration of arsenic in tissues of tilapia was evaluated and an estimation of the risks associated with the consumption of this fish was done, taking into account the guidelines established by FAO/WHO. The inductively coupled plasma mass spectrometry (ICP-MS) technique in kinetic energy discrimination (KED) mode was employed and certified reference materials were analyzed with recoveries of 101, 110, and 80% from NIST 1640a (trace elements in water), NIST 1566b (oyster tissue), and DORM-3 (fish protein). In the consumable portion (the muscle fish tissue), the average concentration found was 0.030 ± 0.008 µg g-1, which is below the arsenic maximum level established by international regulatory agencies. The average concentration found in the viscera (stomach, gills, and liver) was 0.485 ± 0.225 µg g-1, concluding that the viscera had greater capacity for the bioaccumulation of arsenic. From this study was possible to monitor the arsenic element in different tilapia specimens evidencing its accumulation throughout the body of the fish.

Inorganic elements present in pharmaceutical products were determined by inductively coupled plasma-mass spectrometer (ICP-MS), employing microwave acid digestion as a sample preparation method. The most abundant isotopes, 75As+, 65Cu+, 52Cr+, 58Ni+, 208Pb+, and 51V+, were determined in acyclovir ointment and its constituents. Elemental impurities in the pharmaceutical samples were determined using an inductively coupled plasma-universal cell technology-mass spectrometer (ICP-UCT-MS) operated in kinetic energy discrimination (KED) and standard mode. The accuracy of the method was assessed by means of addition and recovery experiments. Except for Cr, spiked recoveries of the elements added to the samples before microwave acid digestion (MW-AD) step were between 95.1 and 126%, and after MW-AD step ranged from 85.6 to 132%. Limits of detection (LOD) obtained by proposed method is in agreement to those required by the U.S. Pharmacopeia Convention (USP), showing that the ICP-MS technique is well suited for quantification of these elements. The LOD's (ng L-1) for 51V+, 52Cr+, 58Ni+, 65Cu+, 75As+ and 208Pb+ in 1% v v-1 HNO3 medium were: 2.2, 81.3, 91.9, 6.9, 0.2 and 3.1, respectively. The concentration of the analytes in these samples presented a wide range, varying from 2.3 ± 0.8 µg kg-1 for As to 3446 ± 47 µg kg-1 for Cr.

The isolation frequency of Arcobacter species in children with diarrhea, fowls, mammals and food of avian and marine origin was established. In all the samples it was possible to isolate Arcobacter species corresponding 201 (39.4%) to A. butzleri and 24 (4.7) to A. cryaerophilus. Both species were simultaneously isolated in 19 (3.7%) being A. butzleri the most frequently isolated species.

Cardiac resynchronization therapy (CRT) is an established treatment modality for systolic heart failure. Aimed to produce simultaneous biventricular stimulation and correct the lack of ventricular synchrony in selected patients with congestive heart failure, CRT has shown to improve mortality and reduce hospital admissions when compared to medical treatment. At present, the indication criteria for the implantation of a CRT device include an ejection fraction of less than 35%, heart failure symptoms consistent with NYHA functional class III-IV and a QRS complex duration equal or longer than 120 milliseconds. It has been reported that 30% of patients who meet those criteria still may not derive clinical benefit from CRT. Due to the existing diversity of imaging modalities and resources for their process and analysis, a great expectation in terms of more accurate diagnosis of ventricular dyssynchrony has been raised. Reliable identification of dyssynchrony could allow us to better predict the favorable response of an individual patient to CRT and therefore offer this procedure to those individuals most likely to benefit. We review the available techniques for the study of ventricular dyssynchrony for CRT patient selection and the results of its application in clinical trials. Despite tremendous progress in the imaging technology available for the assessment and diagnosis of ventricular dyssynchrony, an ideal method has not been identified and the duration of the QRS complex in the surface ECG remains the accepted criteria of dyssynchrony in the selection of patients for CRT.

La terapia de resincronización cardiaca es una modalidad de tratamiento bien establecida para la insuficiencia sistólica cardiaca. Dirigida a producir una estimulación biventricular simultánea y a corregir la falta de sincronía ventricular en pacientes seleccionados con insuficiencia cardiaca congestiva, la terapia de resincronización cardiaca ha mostrado ser capaz de mejorar los índices de mortalidad y reducir las admisiones hospitalarias cuando se compara con el tratamiento médico. Actualmente, los criterios para la implantación de un dispositivo de terapia de resincronización cardiaca incluyen una fracción de eyección menor a 35%, síntomas de insuficiencia cardiaca consistentes con la clase funcional NYHA III-IV, y una duración del complejo QRS igual o mayor de 120 milisegundos. Se ha reportado que 30% de los pacientes que cumplen con estos criterios pueden inclusive no obtener beneficio clínico de la terapia de resincronización cardiaca. Debido a la diversidad existente de los estudios de imagenología y de los recursos para su proceso y análisis, ha surgido una gran expectativa en términos de un diagnóstico más exacto de la asincronía ventricular. La identificación confiable de la asincronía nos podría permitir predecir mejor la respuesta favorable de un paciente en particular a la terapia de resincronización cardiaca y así ofrecer este procedimiento a aquellos pacientes con mayores probabilidades de beneficiarse de dicha terapia. Hacemos una revisión de las técnicas disponibles para el estudio de la asincronía ventricular para la selección de pacientes para esta terapia y los resultados de su aplicación en pruebas clínicas. A pesar de los grandes progresos alcanzados en la tecnología de imágenes disponibles para la evaluación y diagnóstico de la asincronía ventricular, no se ha identificado un método ideal y la duración del complejo QRS en el ECG de superficie sigue siendo el criterio aceptado de asincronía en la selección de pacientes para terapia de resincronización cardiaca.